STATOpinion

AMA CEO: AI won’t replace doctors — it will work alongside them

The goal should not be to reproduce today’s health care system with fewer humans,” writes American Medical Association CEO ...
STAT

Can AI fix health care? In the chaos of emergency rooms, the technology comes up short

CEOs of the biggest AI companies have predicted the technology will “eliminate most cancer” and “improve treatment of most ...
STATOpinion

Autonomous AI will beat AI-assisted physicians at some medical tasks by 2030

Autonomous AI will likely soon exceed both unaided physicians and physicians aided by AI at five core cognitive medical tasks ...
STAT

FDA names acting heads of drug and vaccine centers to permanent roles

WASHINGTON — The Trump administration permanently filled four key leadership roles at the Food and Drug Administration on ...
STAT

AstraZeneca’s experimental COPD treatment posts strong results in late-stage studies

An experimental COPD drug from AstraZeneca could prove competitive with existing treatments, and have a slice of the market ...
STAT

Health care features prominently in Democrats’ agenda

You’re reading the web edition of D.C. Diagnosis, STAT’s twice-weekly newsletter about the politics and policy of health and ...
STAT

Roivant lung disease drug hits mid-stage study goals

Roivant said Tuesday an experimental drug for a type of pulmonary hypertension achieved the goals of a mid-stage study — ...
STAT

FDA approves AstraZeneca breast cancer drug

Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news ...
STAT

Oura goes public, reported $1.2B earnings in its last fiscal year

In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more ...
STAT

Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more

An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study ...
STAT

Read Out of Pocket, Out of Reach.

Get notified when the next part drops Sign up for Health Care Inc., STAT’s free weekly newsletter about the business of health care, to find out when each story is published. You’ll also get sharp ...
STAT

FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals

The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals ...